US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 27, 2016 (10 years ago)

Norditropin FlexPro Somatropin

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step

What was recalled

Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only, Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7703-21

Recalling firm
Novo Nordisk Inc
NDC code
0169-7703-21
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0956-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Somatropin recalls

See all
Class II · Moderate risk Terminated

ZOMA-Jet 10 Demonstration Kit

Reason Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Ferring Pharmaceuticals Inc D-0318-2021
Class II · Moderate risk Terminated

ZOMA-Jet 5 Demonstration Kit

Reason Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

Ferring Pharmaceuticals Inc D-0317-2021
Class II · Moderate risk Terminated

Tev-Tropin

Reason Lack of Assurance of Sterility

Western Drug D-0460-2016
Class II · Moderate risk Terminated

Tev-Tropin

Reason Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying process.

Ferring Pharmaceuticals Inc NDC 57844-713-46 D-1385-2014
Class III · Low risk Terminated

Tev-Tropin

Reason Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A

Ferring Pharmaceuticals Inc D-240-2013